(ACKB) Ackermans Van Haaren - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003764785
ACKB: Marine, Banking, Real Estate, Senior Care, Energy, Resources
Ackermans & Van Haaren NV is a multifaceted conglomerate with a rich history dating back to 1876, offering a diverse portfolio of services across various industries. Its Marine Engineering & Contracting segment is a global leader in dredging and marine construction, playing a crucial role in international trade by ensuring navigable waterways. The companys expertise extends to renewable energy projects, such as offshore wind farms, positioning it well in the growing sustainable energy sector.
The Private Banking division provides bespoke financial services, catering to high-net-worth individuals and entrepreneurs. This segment offers stability through its fee-based revenue model, which is less volatile compared to traditional banking activities, making it an attractive component for investors seeking steady returns.
In Real Estate & Senior Care, the company focuses on mixed-use developments and senior housing, addressing the increasing demand for age-appropriate living solutions in Europe. This segment is poised for growth as the population ages, highlighting a strategic and socially responsible investment opportunity.
The Energy & Resources segment includes sustainable palm oil production and cement manufacturing, aligning with global trends towards renewable resources and sustainable construction materials. This diversification not only spreads risk but also taps into growing markets focused on environmental sustainability.
AvH & Growth Capital serves as the companys venture arm, investing in innovative technologies and R&D. This segment drives future growth through investments in medical devices, biotechnology, and digital media, offering potential high returns and competitive advantages in emerging markets.
Founded in 1876, Ackermans & Van Haaren NVs longevity underscores its stability and adaptability. With a market capitalization of 6176.65M EUR and a P/E ratio of 14.36, the company presents a balanced valuation, suggesting reasonable growth prospects. Investors may find value in its diversified operations and strategic market positions across multiple industries.
Additional Sources for ACKB Stock
ACKB Stock Overview
Market Cap in USD | 7,133m |
Sector | Industrials |
Industry | Engineering & Construction |
GiC Sub-Industry | Multi-Sector Holdings |
IPO / Inception |
ACKB Stock Ratings
Growth 5y | 72.5% |
Fundamental | 63.5% |
Dividend | 61.3% |
Rel. Strength Industry | 4.22 |
Analysts | - |
Fair Price Momentum | 211.06 EUR |
Fair Price DCF | 431.84 EUR |
ACKB Dividends
Dividend Yield 12m | 1.81% |
Yield on Cost 5y | 3.05% |
Annual Growth 5y | 7.94% |
Payout Consistency | 99.4% |
ACKB Growth Ratios
Growth Correlation 3m | 51.8% |
Growth Correlation 12m | 92.3% |
Growth Correlation 5y | 84.6% |
CAGR 5y | 11.91% |
CAGR/Max DD 5y | 0.44 |
Sharpe Ratio 12m | 1.86 |
Alpha | 23.35 |
Beta | 0.15 |
Volatility | 20.56% |
Current Volume | 27.2k |
Average Volume 20d | 22.4k |
As of March 09, 2025, the stock is trading at EUR 198.20 with a total of 27,178 shares traded.
Over the past week, the price has changed by +1.23%, over one month by +4.21%, over three months by +4.92% and over the past year by +28.23%.
Yes, based on ValueRay Fundamental Analyses, Ackermans Van Haaren (BR:ACKB) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 63.48 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACKB as of March 2025 is 211.06. This means that ACKB is currently overvalued and has a potential downside of 6.49%.
Ackermans Van Haaren has no consensus analysts rating.
According to ValueRays Forecast Model, ACKB Ackermans Van Haaren will be worth about 228.2 in March 2026. The stock is currently trading at 198.20. This means that the stock has a potential upside of +15.14%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 214.7 | 8.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 228.2 | 15.1% |